Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes (Q37226729)
Jump to navigation
Jump to search
scientific article published on 25 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes |
scientific article published on 25 July 2013 |
Statements
1 reference
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes (English)
1 reference
John C Byrd
1 reference
Michael A Caligiuri
1 reference
Amy M Lehman
1 reference
Natarajan Muthusamy
1 reference
Jason A Dubovsky
1 reference
Kyle A Beckwith
1 reference
Jennifer A Woyach
1 reference
Karilyn M Larkin
1 reference
Leslie A Andritsos
1 reference
Kami Maddocks
1 reference
Anjali Mishra
1 reference
Gayathri Natarajan
1 reference
Samantha Jaglowski
1 reference
Yiming Zhong
1 reference
Joshua D Hessler
1 reference
Ta-Ming Liu
1 reference
Betty Y Chang
1 reference
Matthew R Stefanovski
1 reference
Danielle L Chappell
1 reference
Frank W Frissora
1 reference
Lisa L Smith
1 reference
Kelly A Smucker
1 reference
Joseph M Flynn
1 reference
Jeffrey A Jones
1 reference
Richard Furman
1 reference
Jeff Sharman
1 reference
Abhay R Satoskar
1 reference
Joseph J Buggy
1 reference
Amy J Johnson
1 reference
25 July 2013
1 reference
1 reference
2539-2549
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference